Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00947947 · ClinicalTrials.gov registry record · Phase 2
Computerized HIV/Sexually Transmitted Disease (STD) Prevention Program
A Phase 2 study, sponsored by University of North Carolina, Chapel Hill.
- Completed
- Registry status
- Phase 2
- Development phase
- 274
- Enrollment target
NCT00947947: Completed Phase 2 study, sponsored by University of North Carolina, Chapel Hill.
NCT00947947 is a Phase 2 study that has completed, run by University of North Carolina, Chapel Hill. The registered enrollment target is 274 participants, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (106% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00947947, a Phase 2 study, has completed, sponsored by University of North Carolina, Chapel Hill.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 274 participants
- Enrollment target
Study Summary
The purpose of the current study is to test a computerized HIV/STD prevention program with heterosexual African Americans. The hypothesis is that those exposed to the program will increase their correct and consistent use of condoms compared to those not exposed to the program.
Interventions
- BEHAVIORAL Tailored Information Program for Safer Sex
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 274 participants |
| Start Date | 2010-02 |
| Est. Completion | 2012-05 |
| Phase | Phase 2 |
What the finished NCT00947947 record still lists
NCT00947947 is an interventional study that assigns participants to a tested intervention. The registered 274 participants enrollment target is mid-sized for trials with a published cap, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (106% higher).
The record links to 0 conditions, and to 1 intervention - of which Tailored Information Program for Safer Sex is the first listed.
NCT00947947 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00947947 about?
NCT00947947 is a clinical study titled "Computerized HIV/Sexually Transmitted Disease (STD) Prevention Program". The purpose of the current study is to test a computerized HIV/STD prevention program with heterosexual African Americans. The hypothesis is that those exposed to the program will increase their correct and consistent use of condoms compared to those not exposed to the program.
What is the current status of trial NCT00947947?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 274 participants. The study started on 2010-02. Estimated completion is 2012-05.
What interventions are being tested in trial NCT00947947?
The interventions under investigation include: Tailored Information Program for Safer Sex (BEHAVIORAL).
Who is sponsoring clinical trial NCT00947947?
This trial is sponsored by University of North Carolina, Chapel Hill, which has 1,109 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00947947's enrollment target sits among peer trials
274 203rd of 2000 higher than 1,797 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03808922 · 274 participants · Phase 3
Phase III DAS181 Lower Tract PIV Infection in Immunocompromised Subjects (Substudy: DAS181 for COVID-19): RCT Study
- NCT04573504 · 274 participants · Phase 4
Antibiotics for Severe Perineal Laceration to Prevent Infection Following Repair
- NCT05289557 · 274 participants · Phase 3
The Efficacy and Safety of Bonjesta® for Nausea and Vomiting of Pregnancy in Pregnant Adolescents
- NCT05952583 · 274 participants
Selective Fetal Growth Restriction in Monochorionic Twins - an International Investigation
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia